Eurobio Scientific Société anonyme (FRA:E8TN)

Market Cap	223.01M -12.4%
Revenue (ttm)	162.47M +12.4%
Net Income	2.36M -64.4%
EPS	0.22 -62.6%
Shares Out	n/a
PE Ratio	94.42
Forward PE	27.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	21.95
Previous Close	22.00
Day's Range	21.95 - 21.95
52-Week Range	20.75 - 25.75
Beta	n/a
RSI	46.60
Earnings Date	Apr 10, 2026

About FRA:E8TN

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monitoring; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune stat...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1997
• Employees: 380
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: E8TN

Financial Performance

In 2024, FRA:E8TN's revenue was 154.95 million, an increase of 18.60% compared to the previous year's 130.65 million. Earnings were 4.00 million, a decrease of -17.31%.